Sign In
Buy HUM
$327.54
+6.66 (+2.08%)
At Close: Jun 03, 2026
HUM ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Humana Inc. investment
10:07am, Sunday, 04'th May 2025
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of fe
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Investors to Inquire about Securities Investigation
10:00am, Sunday, 04'th May 2025
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Inves
Investors who lost money on Humana Inc. should contact Levi & Korsinsky about an ongoing investigation - HUM
06:01pm, Saturday, 03'rd May 2025
NEW YORK, NY / ACCESS Newswire / May 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of fe
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
10:00am, Saturday, 03'rd May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to co
Levi & Korsinsky Announces an Investigation on Behalf of Humana Inc. (HUM) Shareholders Who May Have Been Affected by Fraud
06:15pm, Friday, 02'nd May 2025
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of fe
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
06:00pm, Friday, 02'nd May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to co
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of fe
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Inves
Aetna, Humana sued by feds over alleged Medicare kickback scheme
04:03pm, Thursday, 01'st May 2025
The insurers engaged in a vast kickback scheme with insurance brokers eHealth, GoHealth and SelectQuote from 2016 to 2021, the DOJ alleged.
Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength
02:45pm, Wednesday, 30'th Apr 2025
HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.
CNC vs. HUM: Which Stock Is the Better Value Option?
12:40pm, Wednesday, 30'th Apr 2025
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC) and Humana (HUM). But which of these two stocks presents investors with the better value oppo
Humana Cost Cuts, Medicare Advantage Moves Boost Results
11:09am, Wednesday, 30'th Apr 2025
Humana (HUM) shares edged higher when the health insurer reported better-than-expected results as it lowered costs and pulled out of certain Medicare Advantage plans.
Humana (HUM) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 30'th Apr 2025
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Humana, Inc. (HUM) Q1 2025 Earnings Call Transcript
09:40am, Wednesday, 30'th Apr 2025
Humana, Inc. (NYSE:HUM ) Q1 2025 - Earnings Conference Call April 30, 2025 8:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Re
Humana's exit of some ‘unprofitable' Medicare plans helps fuel a big profit beat
08:55am, Wednesday, 30'th Apr 2025
While Humana affirmed its full-year profit outlook, which can be viewed as a positive in the current uncertain economic environment, quarterly revenue came up a bit shy, and the earnings outlook for t
